Group One Trading’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-409
Closed -$19K 8148
2022
Q4
$14.5K Buy
+409
New +$49.1K ﹤0.01% 5820
2022
Q2
Sell
-290
Closed -$58.5K 8734
2022
Q1
$72K Buy
290
+225
+346% +$35.6K ﹤0.01% 5817
2021
Q4
$10K Buy
+65
New +$12.6K ﹤0.01% 7371
2020
Q4
Sell
-147
Closed -$36K 7140
2020
Q3
$36K Buy
+147
New +$45.7K ﹤0.01% 4845
2020
Q2
Sell
-7
Closed -$1K 6303
2020
Q1
$1K Hold
7
﹤0.01% 5128
2019
Q4
$3K Buy
+7
New +$2.48K ﹤0.01% 4858
2019
Q3
Hold
0
5672
2019
Q2
Hold
0
5502
2019
Q1
Hold
0
5492
2018
Q4
Hold
0
5545
2018
Q3
Hold
0
5720
2018
Q2
Hold
0
5571
2018
Q1
Hold
0
5412
2017
Q4
Hold
0
5324
2017
Q3
Hold
0
5259
2017
Q2
Hold
0
5192
2017
Q1
Sell
-1
Closed -$344 5097
2016
Q4
$0 Hold
1
﹤0.01% 4927
2016
Q3
$0 Hold
1
﹤0.01% 5001
2016
Q2
$0 Sell
1
-112
-99% -$68K ﹤0.01% 5019
2016
Q1
$57K Buy
113
+67
+146% +$33.4K ﹤0.01% 3188
2015
Q4
$30K Sell
46
-50
-52% -$28.3K ﹤0.01% 3714
2015
Q3
$45K Buy
96
+51
+113% +$27.1K ﹤0.01% 3591
2015
Q2
$26K Buy
+45
New +$125K ﹤0.01% 3913

Other funds holding EIGR

Group One Trading's EIGR Position: Q1 2023 in Review

Group One Trading sold out of Eiger BioPharmaceuticals, Inc. (EIGR) in Q1 2023, closing a stake of 409 shares — an estimated $19K sold.

Group One Trading first reported a position in EIGR in Q2 2015 and held it in 13 quarters. The position peaked at $72K in Q1 2022. 71 funds tracked by Wall St. Rank hold EIGR as of Q1 2023.

  • Group One Trading reported no remaining Eiger BioPharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
  • Group One Trading sold 409 Eiger BioPharmaceuticals, Inc. shares in Q1 2023, an estimated $19K.
  • Group One Trading first reported a position in Eiger BioPharmaceuticals, Inc. in Q2 2015 and held it in 13 quarters.
  • Group One Trading's Eiger BioPharmaceuticals, Inc. position peaked at $72K in Q1 2022.
  • 71 funds tracked by Wall St. Rank held Eiger BioPharmaceuticals, Inc. as of Q1 2023.

Based on Group One Trading's 13F filing for Q1 2023, filed 12 May 2023.